Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 3:43 PM ET

Pharmaceuticals

Company Overview of Merial Inc.

Company Overview

Merial Inc. engages in the manufacture and distribution of animal healthcare products and pharmaceuticals. The company is based in Duluth, Georgia. Merial Inc. operates as a subsidiary of Sanofi.

3239 Satellite Boulevard

Building 500

Duluth, GA 30096

United States

Key Executives for Merial Inc.

Chief Executive Officer
Age: 50
Global Head of R&D
Compensation as of Fiscal Year 2014.

Merial Inc. Key Developments

Merial Appoints Fabian Kausche to Lead Global Research & Development

Merial announced that Fabian Kausche will be leading the company's global research and development (R&D) efforts, effective June 9, 2014. Dr. Kausche brings to the company a wide range of global experience in pharmaceutical and biological R&D and business leadership positions, at both human and animal health companies. Dr. Kausche joins Merial after 10 years at Novartis, where he was most recently global Head of R&D for Animal Health. As the new Global Head of R&D, Dr. Kausche will be based in Duluth, Ga., USA, with responsibility for advancing Merial's leadership in the discovery and development of innovative vaccines and therapies for companion and production animals. He will lead Merial's global R&D team, including more than 700 scientists and support staff at R&D sites around the world, to advance more than 50 projects currently in development for a variety of animal species. Fabian Kausche will be a member of the Merial Leadership Team and will report to Merial CEO Carsten Hellmann. He will also be a member of the Sanofi R&D Leadership Team.

Similar Private Companies By Industry

Company Name Region
TargeGen Inc. United States
Shire Human Genetic Therapies, Inc. United States
Tolmar Therapeutics, Inc. United States
Skinvera LLC United States
Sirion Holdings, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 17, 2014
Bayer HealthCare AG, Legend®/Hyonate® And Marquis®
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Merial Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.